Success Metrics

Clinical Success Rate
25.0%

Based on 1 completed trials

Completion Rate
25%(1/4)
Active Trials
4(40%)
Results Posted
100%(1 trials)
Terminated
3(30%)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
3
30%
Ph phase_2
4
40%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
4(50.0%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

20.0%

1 of 5 finished

Non-Completion Rate

80.0%

4 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(1)
Terminated(4)
Other(1)

Detailed Status

Terminated3
Recruiting3
Completed1
Active, not recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
25.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (50.0%)
Phase 41 (12.5%)
N/A3 (37.5%)

Trials by Status

completed110%
terminated330%
active_not_recruiting110%
unknown110%
recruiting330%
withdrawn110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10